Tech Center 1600 • Art Units: 1634 1671 1682 1683
This examiner grants 43% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18050855 | METHODS AND SYSTEMS FOR IMPROVING PATIENT MONITORING AFTER SURGERY | Non-Final OA | GUARDANT HEALTH, INC. |
| 17489677 | METHODS AND SYSTEMS TO IMPROVE THE SIGNAL TO NOISE RATIO OF DNA METHYLATION PARTITIONING ASSAYS | Non-Final OA | GUARDANT HEALTH, INC. |
| 16309271 | COMPOSITIONS AND METHODS FOR DETECTION OF NUCLEIC ACID MUTATIONS | Final Rejection | Natera, Inc. |
| 18174491 | BREAST CANCER-RESPONSE PREDICTION SUBTYPES | Non-Final OA | The Regents of The University of California |
| 16848989 | NONINVASIVE DIAGNOSTICS BY SEQUENCING 5-HYDROXYMETHYLATED CELL-FREE DNA | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17984444 | SURFACE-ENHANCED RAMAN SCATTERING (SERS) BIOSENSOR FOR DIAGNOSING PROSTATE CANCER WITH HIGH SENSITIVITY | Non-Final OA | Korea University Research and Business Foundation |
| 18152346 | Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) Variants And Uses Thereof | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 18595057 | DIAGNOSIS OF ACUTE AND CHRONIC LUNG DISEASES BY QUANTIFYING SPINK1 LEVEL | Non-Final OA | Northwestern University |
| 18548175 | CELL-FREE BIOSENSORS WITH DNA STRAND DISPLACEMENT CIRCUITS | Non-Final OA | Northwestern University |
| 18023538 | CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS FOR VIRUS DETECTION | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18463282 | USE OF SDHA AS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN UVEAL MELANOMA | Final Rejection | Board of Regents, The University of Texas System |
| 18269171 | SELECTIVE LYSIS OF HUMAN BLOOD CELLS | Final Rejection | Roche Molecular Systems, Inc. |
| 18276223 | BIOMARKERS FOR CANCER TREATMENT | Non-Final OA | Foundation Medicine, Inc. |
| 18575242 | ANALOG CIRCUIT TO COMPENSATE BIAS OFFSET IN AMPLIFIER ARRAY | Non-Final OA | ILLUMINA, INC. |
| 18013178 | METHOD FOR DETECTING COLORECTAL CANCER | Non-Final OA | ACADEMISCH ZIEKENHUIS MAASTRICHT |
| 16633183 | NEW SUBPOPULATIONS OF CANCER ASSOCIATED FIBROBLASTS AS PROGNOSIS MARKERS FOR IMMUNOTHERAPY TREATMENTS | Final Rejection | INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) |
| 18509538 | Method for Detecting Thyroid Tumor Based on Imprinted Gene Analysis | Non-Final OA | LISEN IMPRINTING DIAGNOSTICS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy